Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride for neuroprotection in acute optic neuritis
2012-004980-39Phase 2Unknown
- Sponsor
- University of Oxford
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in optic neuritis (ON) comparing Amiloride with Placebo (2 arms). Primary endpoint: Retinal nerve fibre layer thickness by GDx at 6 months. Status: unknown.
02
Drugs
amiloride
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on 2012-004980-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004980-39.